A. Kistner

发表

Neurostimulation for Parkinson's disease with early motor complications.

G. Deuschl, G. Fink, Y. Agid, 2013, The New England journal of medicine.

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.

L. Tremblay, A. Benabid, P. Pollak, 2010, Brain : a journal of neurology.

Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.

Eric Seigneuret, Paul Krack, Valérie Fraix, 2012, Brain : a journal of neurology.

Does Motor Symptoms Asymmetry Predict Motor Outcome of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients?

S. Chabardès, E. Moro, V. Fraix, 2022, Frontiers in Human Neuroscience.

Author response: Dementia and subthalamic deep brain stimulation in Parkinson disease: A long-term overview

A. Benabid, P. Krack, S. Chabardès, 2020 .

Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation

S. Chabardès, E. Moro, V. Fraix, 2022, npj Parkinson's Disease.

Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease

B. Debu, P. Krack, S. Chabardès, 2022, European journal of neurology.

Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease

P. Krack, S. Chabardès, E. Moro, 2020, Annals of neurology.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease

G. Deuschl, G. Fink, Y. Agid, 2019, Neurology.

Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease

P. Krack, S. Chabardès, E. Moro, 2021, Neurology.

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.

Paul Krack, Jean-Luc Bosson, Stephan Chabardes, 2013, Brain : a journal of neurology.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

G. Deuschl, G. Fink, Y. Agid, 2018, The Lancet Neurology.

Subthalamic stimulation and neuropsychiatric symptoms in Parkinson’s disease: results from a long-term follow-up cohort study

P. Krack, S. Chabardès, E. Moro, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Dementia and subthalamic deep brain stimulation in Parkinson disease

A. Benabid, P. Krack, S. Chabardès, 2020, Neurology.

Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease

P. Pollak, P. Krack, S. Chabardès, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Psychostimulant effect of levodopa: reversing sensitisation is possible

P. Pollak, P. Krack, S. Chabardès, 2012, Journal of Neurology, Neurosurgery & Psychiatry.

Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease

G. Deuschl, M. Vidailhet, C. Hartmann, 2022, Movement disorders : official journal of the Movement Disorder Society.

Mechanisms of Body Weight Fluctuations in Parkinson’s Disease

P. Krack, A. Kistner, E. Lhommée, 2014, Front. Neurol..

Parkinson’s Disease: No Milk Today?

P. Krack, A. Kistner, 2014, Front. Neurol..

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease

C. Lüscher, P. Pollak, P. Krack, 2017, Movement disorders : official journal of the Movement Disorder Society.

Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation

Paul Krack, Valérie Fraix, Stéphane Thobois, 2017, Movement disorders : official journal of the Movement Disorder Society.

Profile of Neuropsychiatric Symptoms in Parkinson's Disease: Surgical Candidates Compared to Controls.

P. Krack, V. Fraix, R. Esselink, 2016, Journal of Parkinson's disease.

Fluctuations in Parkinson’s disease and personalized medicine: bridging the gap with the neuropsychiatric fluctuation scale